Track topics on Twitter Track topics that are important to you
Fourth Quarter Adjusted EBITDA Profit of $409k, Resulting in nearly a $1 million Improvement; Year-Over-Year
Fourth Quarter and Full Year Fiscal 2018 Sales Increase of 48% and 13% respectively; Year-Over-Year
Fourth Quarter and Full Year Fiscal 2018 Gross Profit Increase of 80% and 14% respectively; Year-Over-Year
HOLLYWOOD, Fla., March 28, 2019 (GLOBE NEWSWIRE)NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...